Cargando…

Osteopontin targeted theranostic nanoprobes for laser-induced synergistic regression of vulnerable atherosclerotic plaques

Vulnerable atherosclerotic plaque (VASPs) is the major pathological cause of acute cardiovascular event. Early detection and precise intervention of VASP hold great clinical significance, yet remain a major challenge. Photodynamic therapy (PDT) realizes potent ablation efficacy under precise manipul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Mengqi, Mao, Cong, Chen, Haoting, Liu, Lu, Wang, Yabin, Hussain, Abid, Li, Sulei, Zhang, Xu, Tuguntaev, Ruslan G., Liang, Xing-Jie, Guo, Weisheng, Cao, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279717/ https://www.ncbi.nlm.nih.gov/pubmed/35847489 http://dx.doi.org/10.1016/j.apsb.2021.12.020

Ejemplares similares

IVUS\IVPA hybrid intravascular molecular imaging of angiogenesis in atherosclerotic plaques via RGDfk peptide-targeted nanoprobes
por: Lin, Lejian, et al.
Publicado: (2021)

Dual-modality Imaging of Angiogenesis in Unstable Atherosclerotic Plaques with VEGFR2-Targeted Upconversion Nanoprobes in vivo
por: Fang, Yan, et al.
Publicado: (2022)

Osteopontin and osteoprotegerin in atherosclerotic plaque – are they significant markers of plaque vulnerability?
por: Strobescu-Ciobanu, Cristina, et al.
Publicado: (2020)

Precise theranostic nanomedicines for inhibiting vulnerable atherosclerotic plaque progression through regulation of vascular smooth muscle cell phenotype switching
por: Ma, Sai, et al.
Publicado: (2018)

Expression of osteopontin in calcified coronary atherosclerotic plaques.
por: Kwon, H. M., et al.
Publicado: (2000)

Nanoprobes for Tumor Theranostics
por: Zhu, Jiaoyang, et al.
Publicado: (2022)

Bioimaging guided pharmaceutical evaluations of nanomedicines for clinical translations
por: Tuguntaev, Ruslan G., et al.
Publicado: (2022)

Impact of Alirocumab on Release Markers of Atherosclerotic Plaque Vulnerability in Patients with Mixed Hyperlipidemia and Vulnerable Atherosclerotic Plaque
por: Kosowski, Michał, et al.
Publicado: (2022)

Atherosclerotic Plaque Biomarkers: Beyond the Horizon of the Vulnerable Plaque
por: W. van Lammeren, Guus, et al.
Publicado: (2011)

Correlation Between Calcification Characteristics of Carotid Atherosclerotic Plaque and Plaque Vulnerability
por: Xu, Xiangli, et al.
Publicado: (2021)

Stimuli-responsive polymeric nanomaterials for rheumatoid arthritis therapy
por: Xie, Yingsi, et al.
Publicado: (2020)

Tunable Plasmonic Nanoprobes for Theranostics of Prostate Cancer
por: Lukianova-Hleb, Ekaterina Y., et al.
Publicado: (2011)

Ultrasound Tissue Characterization of Vulnerable Atherosclerotic Plaque
por: Picano, Eugenio, et al.
Publicado: (2015)

Nuclear Molecular Imaging for Vulnerable Atherosclerotic Plaques
por: Lee, Soo Jin, et al.
Publicado: (2015)

Coronary Atherosclerotic Vulnerable Plaque: Current Perspectives
por: Stefanadis, Christodoulos, et al.
Publicado: (2017)

Immune-Mediated Inflammation in Vulnerable Atherosclerotic Plaques
por: Mangge, Harald, et al.
Publicado: (2019)

Calcification in Atherosclerotic Plaque Vulnerability: Friend or Foe?
por: Shi, Xuan, et al.
Publicado: (2020)

Colchicine reduces atherosclerotic plaque vulnerability in rabbits
por: Roubille, François, et al.
Publicado: (2021)

Vulnerable Atherosclerotic Plaque: Is There a Molecular Signature?
por: Chiorescu, Roxana Mihaela, et al.
Publicado: (2022)

Atherosclerotic plaque vulnerability quantification system for clinical and biological interpretability
por: Zhang, Ge, et al.
Publicado: (2023)

The prevention and regression of atherosclerotic plaques: emerging treatments
por: Kalanuria, Atul Ashok, et al.
Publicado: (2012)

Statin effects on atherosclerotic plaques: regression or healing?
por: Bittencourt, Marcio Sommer, et al.
Publicado: (2015)

Current advances in the imaging of atherosclerotic vulnerable plaque using nanoparticles
por: Zhang, Ming, et al.
Publicado: (2022)

Retraction of “Tunable Plasmonic Nanoprobes for Theranostics of Prostate Cancer”
por: Lukianova-Hleb, Ekaterina Y., et al.
Publicado: (2017)

Molecular Imaging of Vulnerable Atherosclerotic Plaques in Animal Models
por: Gargiulo, Sara, et al.
Publicado: (2016)

Atherosclerotic plaque vulnerability is increased in mouse model of lupus
por: Santiago-Raber, Marie-Laure, et al.
Publicado: (2020)

BIRC6 Is Associated with Vulnerability of Carotid Atherosclerotic Plaque
por: Alloza, Iraide, et al.
Publicado: (2020)

The use of theranostic gadolinium-based nanoprobes to improve radiotherapy efficacy
por: Sancey, L, et al.
Publicado: (2014)

A Theranostic Nanoprobe for Hypoxia Imaging and Photodynamic Tumor Therapy
por: Fan, Jing Hao, et al.
Publicado: (2019)

Small entities with large impact: microcalcifications and atherosclerotic plaque vulnerability
por: Hutcheson, Joshua D., et al.
Publicado: (2014)

The role of near-infrared spectroscopy in the detection of vulnerable atherosclerotic plaques
por: Horvath, Martin, et al.
Publicado: (2016)

Lectin Pathway of Complement Activation Is Associated with Vulnerability of Atherosclerotic Plaques
por: Fumagalli, Stefano, et al.
Publicado: (2017)

Establishment of a Novel Mouse Model for Atherosclerotic Vulnerable Plaque
por: Wang, Xueyu, et al.
Publicado: (2021)

Vulnerable atherosclerotic plaque features: findings from coronary imaging
por: Kurihara, Osamu, et al.
Publicado: (2021)

Non-Invasive Modalities in the Assessment of Vulnerable Coronary Atherosclerotic Plaques
por: Theofilis, Panagiotis, et al.
Publicado: (2022)

cGAS-STING Pathway Performance in the Vulnerable Atherosclerotic Plaque
por: Wan, Xueqi, et al.
Publicado: (2022)

Cholesterol in human atherosclerotic plaque is a marker for underlying disease state and plaque vulnerability
por: Chen, Zhu, et al.
Publicado: (2010)

Low‐Intensity Focused Ultrasound‐Responsive Ferrite‐Encapsulated Nanoparticles for Atherosclerotic Plaque Neovascularization Theranostics
por: Yao, Jianting, et al.
Publicado: (2021)

Mast cells in vulnerable atherosclerotic plaques – a view to a kill
por: Lindstedt, Ken A, et al.
Publicado: (2007)

Is Cadmium Exposure Associated with the Burden, Vulnerability and Rupture of Human Atherosclerotic Plaques?
por: Bergström, Göran, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8gt94vechb1o4ibrutu1i26046